Khiron Life Sciences Corp. will be speaking at the Benzinga Global Small Cap Conference set to take place on December 8-9, 2020.
Legal cannabis is gaining momentum in Latin America for its wide range of applications within the medical sector. Colombia just became one of a growing group of countries in which the healthcare system covers cannabis products.
Khiron Life Sciences Corp (OTCQX: KHRNF), a vertically integrated Colombian cannabis company with operations in Latin America, Europe, and North America, is a part of the companies that currently are filling medical cannabis prescriptions within Colombia ,Peru and The UK. The company was recently certified as a National Strategic Project by the Colombian Government (PINES status), and its products will be covered through the Colombian platform MIPRES.
Colombian Medical Platform MIPRES, is a technological tool that allows healthcare professionals to prescribe medical products not financed with resources from the government or complimentary services. This milestone will open the doors to other cannabis products to reinforce this emerging market’s potential.
“We see the inclusion of our products and services under health insurance policies as …